Reviva Pharmaceuticals’ (RVPH) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research report released on Thursday morning,Benzinga reports. D. Boral Capital currently has a $8.00 price objective on the stock. RVPH has been the subject of a number of other research reports. Roth Mkm assumed coverage on shares […]
D. Boral Capital reiterated their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research report released on Thursday morning,Benzinga reports. D. Boral Capital currently has a $8.00 price objective on the stock. RVPH has been the subject of a number of other research reports. Roth Mkm assumed coverage on shares […]
